These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 3992523)
1. The involvement of platelets and the coronary vasculature in collagen-induced sudden death in rabbits. Mallarkey G; Smith GM Thromb Haemost; 1985 Feb; 53(1):70-4. PubMed ID: 3992523 [TBL] [Abstract][Full Text] [Related]
2. Mouse antithrombotic assay: the effects of Ca++ channel blockers are platelet-independent. Molinari A; Guarneri L; Pacei E; de Marchi F; Cerletti C; de Gaetano G J Pharmacol Exp Ther; 1987 Feb; 240(2):623-7. PubMed ID: 3806414 [TBL] [Abstract][Full Text] [Related]
3. Differential actions of naftopidil, doxazosin and nifedipine on platelet thromboxane generation and platelet-derived growth factor efflux in vitro. Alarayyed NA; Prichard BN; Betteridge DJ; Smith CC Platelets; 2002; 13(5-6):267-71. PubMed ID: 12189011 [TBL] [Abstract][Full Text] [Related]
4. Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil. Han P; Boatwright C; Ardlie NG Thromb Haemost; 1983 Aug; 50(2):513-7. PubMed ID: 6314581 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of the protective action of Bay-u-3405, a new specific thromboxane receptor antagonist, in arachidonate-induced sudden death. Ma XL; Karasawa A; Lefer AM Methods Find Exp Clin Pharmacol; 1991 Mar; 13(2):105-10. PubMed ID: 1906568 [TBL] [Abstract][Full Text] [Related]
6. Trimucytin: a collagen-like aggregating inducer isolated from Trimeresurus mucrosquamatus snake venom. Teng CM; Ko FN; Tsai IH; Hung ML; Huang TF Thromb Haemost; 1993 Mar; 69(3):286-92. PubMed ID: 8470053 [TBL] [Abstract][Full Text] [Related]
7. Verapamil and collagen-induced platelet reactions--evidence for a role for intracellular calcium in platelet activation. Han P; Boatwright C; Ardlie NG Thromb Haemost; 1983 Aug; 50(2):537-40. PubMed ID: 6415847 [TBL] [Abstract][Full Text] [Related]
8. Alteration of release and role of adenosine diphosphate and thromboxane A2 during collagen-induced aggregation of platelets from cattle with Chediak-Higashi syndrome. Honda N; Ohnishi K; Fujishiro T; Ikeda M; Ito K Am J Vet Res; 2007 Dec; 68(12):1399-406. PubMed ID: 18052747 [TBL] [Abstract][Full Text] [Related]
9. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension. Ding YA; Chou TC; Lin KC J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of platelet function of antiarrhythmic drugs, verapamil and disopyramide. Han P; Boatwright C; Ardlie NG Thromb Haemost; 1982 Apr; 47(2):150-3. PubMed ID: 7101234 [TBL] [Abstract][Full Text] [Related]
11. Role of thromboxane A2, 5-hydroxytryptamine, and platelet activating factor in collagen-induced sudden death in rabbits. Robertson DN; Smith GM Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():204-7. PubMed ID: 2959049 [No Abstract] [Full Text] [Related]
12. A study of platelet aggregation, thromboxane A2 and prostacyclin in central aortic and coronary sinus blood in ischemic heart disease. Narain VS; Bhargava B; Chandra N; Puri VK; Hasan M Indian Heart J; 1994; 46(4):149-52. PubMed ID: 7875701 [TBL] [Abstract][Full Text] [Related]
13. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate. Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331 [TBL] [Abstract][Full Text] [Related]
14. Antiplatelet activity of J78 (2-Chloro-3-[2'-bromo, 4'-fluoro-phenyl]-amino-8-hydroxy-1,4-naphthoquinone), an antithrombotic agent, is mediated by thromboxane (TX) A2 receptor blockade with TXA2 synthase inhibition and suppression of cytosolic Ca2+ mobilization. Jin YR; Cho MR; Ryu CK; Chung JH; Yuk DY; Hong JT; Lee KS; Lee JJ; Lee MY; Lim Y; Yun YP J Pharmacol Exp Ther; 2005 Jan; 312(1):214-9. PubMed ID: 15328379 [TBL] [Abstract][Full Text] [Related]
15. Platelet aggregating response to platelet activating factor participates in activation of the 12-lipoxygenase pathway in platelets from rabbits. Michibayashi T Int Angiol; 2002 Sep; 21(3):260-7. PubMed ID: 12384648 [TBL] [Abstract][Full Text] [Related]
16. Effects of MN-9202 on platelet aggregation, 5-HT release, TXB2 synthesis, and calcium mobilization in rabbit platelets in vitro. Wang LL; Mei QB; Zhao DH; Guo ZA Acta Pharmacol Sin; 2000 Jul; 21(7):623-6. PubMed ID: 11360670 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death. Patscheke H; Stegmeier K; Müller-Beckmann B; Sponer G; Staiger C; Neugebauer G Biomed Biochim Acta; 1984; 43(8-9):S312-8. PubMed ID: 6097235 [TBL] [Abstract][Full Text] [Related]
18. Antagonism of platelet aggregation by 13-azaprostanoic acid in acute myocardial ischemia and sudden death. Burke SE; Roth DM; Lefer AM Thromb Res; 1983 Mar; 29(5):473-88. PubMed ID: 6857596 [TBL] [Abstract][Full Text] [Related]
19. Platelet function in blood from the coronary sinus in patients with arteriosclerotic heart disease. Thaulow E Thromb Haemost; 1983 Oct; 50(3):629-32. PubMed ID: 6228029 [TBL] [Abstract][Full Text] [Related]
20. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization. Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]